Henry Schein, Inc.

HSIC Healthcare Medical Distribution

Henry Schein, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.2 billion, up 4.03% from fiscal 2024. In the quarter to June 2026, revenue grew 6.73%, EPS grew 16.9%, free cash flow grew 140.9% and total debt rose 15.2%, each against the same quarter a year earlier. Member of the S&P 500; insiders bought in the last twelve months.

86.38 0.61 −0.70%
Market cap
$9.7B
P/E
25.0×
Fwd P/E
18.5×
Dividend yield
—
F-score
5/9
Altman Z
2.66
Beneish M
−2.51
Dividend safety
69/100
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

20.81 22.90 22.07 24.14
P/S ratio
0.62 0.69 0.63 0.70
P/FCF ratio
19.80 15.94 19.04 16.65
P/Operating CF
45.85 23.97 (87.33) 39.15
P/B ratio
1.98 2.34 2.16 2.48
EV/Sales
0.77 0.86 0.80 0.86
EV/EBITDA
10.42 11.74 10.94 11.69
EV/FCF
24.88 19.75 24.03 20.66
Current Ratio
1.40 1.38 1.36 1.32
Net Debt/EBITDA
8.42 8.93 8.46 8.95
Debt/Equity
0.54 0.60 0.60 0.64
Earnings Yield
4.81% 4.37% 4.53% 4.14%
Free Cash Flow Yield
5.05% 6.28% 5.25% 6.01%
Free Cash Flow per Share
1.17 2.80 (1.06) 1.87
Book value per Share
33.47 32.27 34.10 33.64
Free Cash Flow
141.00 338.00 (122.00) 212.00
EV/EBIT
15.54 17.33 16.20 17.29
Other line items

Show all line items

Columns are period end dates